Report Links Osteoporosis Drug to Esophagus Cancer

Fosamax May Be Tied to 23 Cases of Esophageal Cancer, Report Says

"There could be some worrying news for the tens of millions of Americans currently taking Fosamax. A brief report published today in the New England Journal of Medicine suggests a possible link between the osteoporosis drug and the development of esophageal cancer. The report, written by U.S. Food and Drug Administration official Diane Wysowski and published in the current New England Journal of Medicine, reveals that the FDA received 23 reports of esophageal cancer possibly linked to the drug between its October 1995 debut and May 2008. Of these patients, eight have died so far, according to the report."

Read this article on ABC NEWS.